Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Stop targeting humanitarian workers
03/08/2017. Humanitarian workers have to balance the risks they are facing with the life-saving impact of their humanitarian work.
Hope for Palmyra’s Future
04/04/2016. After Islamic State retreated last month, a plan to rebuild an ancient city
Presence and Proximity, To Stay and Deliver, Five years On
06/22/2017. How have humanitarian organizations changed the ways they manage security risks ?
